1. Glycogen Storage Disease Phenotypes Accompanying the Perturbation of the Methionine Cycle in NDRG3-Deficient Mouse Livers
   Hyun Ahm Sohn et al, 2022, Cells CrossRef
2. NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
   Sukanya B. Jadhav et al, 2024, Frontiers in Pharmacology CrossRef
3. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis
   Jinju Liu et al, 2020, Human Cell CrossRef
4. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients
   Jun Liu et al, 2021, Journal of Oncology CrossRef
5. Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1
   Jiawei Chang et al, 2023, Cancers CrossRef
6. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
   Dingyuan Hu et al, 2018, Oncotarget CrossRef
7. NDRG1 and FOXO1 regulate endothelial cell proliferation in infantile haemangioma
   Ji Won Byun et al, 2018, Experimental Dermatology CrossRef
8. New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy
   Gang Wang et al, 2019, Journal of Cellular Physiology CrossRef
9. Glycolysis and the Hexosamine Biosynthetic Pathway as Novel Targets for Upper and Lower Airway Inflammation
   Young Hyo Kim et al, 2018, Allergy, Asthma & Immunology Research CrossRef
10. Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential
    Zhong Zhang et al, 2021, Expert Opinion on Therapeutic Targets CrossRef
11. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
    Wenke Yin et al, 2023, Open Medicine CrossRef
12. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
    Claudia Curcio et al, 2021, Molecules CrossRef
13. Regulation of plastin 1 expression modulates pancreatic carcinoma progression by affecting the glycolytic signaling pathway
    Aitao SUN et al, 2024, Minerva Biotechnology and Biomolecular Research CrossRef
14. Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells
    Francesca Chiarini et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
15. The role of autophagy in pancreatic cancer progression
    Yuanyang Wang et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
16. A review on the role of NDRG1 in different cancers
    Soudeh Ghafouri-Fard et al, 2023, Molecular Biology Reports CrossRef
17. Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif
    Guo-Rung You et al, 2022, Cells CrossRef